Phase 3 Sophia Study of Margetuximab plus Chemotherapy Vs Trastuzumab plus Chemotherapy in Patients with Her2+Metastatic Breast Cancer After Prior Anti-Her2 Therapies: Second Interim Overall Survival Analysis
AuthID
P-00S-87X
P-00S-87X